PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.\', \'Department of Internal Medicine, University of California Davis, Sacramento, California, USA.\', \'Pharmaceutical Medicine & Infectious Diseases, Shahin Gharakhanian MD Consulting LLC, Cambridge Innovation Center (CIC), Cambridge, Massachusetts, USA.\', \'Department of Research and Development, Entera Health, LLC, Ankeny, Iowa, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/ddr.21841
?:doi
?:hasPublicationType
?:journal
  • Drug development research
is ?:pmid of
?:pmid
?:pmid
  • 34110032
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.65
?:rankingScore_hIndex
  • 53
is ?:relation_isRelatedTo_publication of
?:title
  • Potential use of serum-derived bovine immunoglobulin/protein isolate for the management of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all